Baker Brothers Advisors - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$1,409,000
-39.0%
474,400
-5.1%
0.01%
-40.0%
Q2 2020$2,310,000
-43.4%
500,000
-52.9%
0.01%
-60.0%
Q1 2020$4,084,000
-18.8%
1,060,714
-21.0%
0.02%
-7.4%
Q4 2019$5,032,000
-29.4%
1,341,9020.0%0.03%
-43.8%
Q3 2019$7,125,000
-27.5%
1,341,902
-47.6%
0.05%
-28.4%
Q2 2019$9,828,000
-33.5%
2,559,461
-11.7%
0.07%
-29.5%
Q1 2019$14,790,000
+165.6%
2,900,0000.0%0.10%
+106.5%
Q4 2018$5,568,000
-49.2%
2,900,0000.0%0.05%
-36.1%
Q3 2018$10,962,000
-3.0%
2,900,000
-19.9%
0.07%
-15.3%
Q2 2018$11,301,000
+7.9%
3,621,962
-17.3%
0.08%
-4.5%
Q1 2018$10,471,000
-54.2%
4,381,072
-25.1%
0.09%
-55.1%
Q4 2017$22,882,000
+78.0%
5,852,153
+14.7%
0.20%
+90.4%
Q3 2017$12,857,000
-8.7%
5,102,1530.0%0.10%
-15.4%
Q2 2017$14,082,000
+41.5%
5,102,1530.0%0.12%
+51.9%
Q1 2017$9,949,000
+85.7%
5,102,1530.0%0.08%
+52.8%
Q4 2016$5,357,000
-3.7%
5,102,1530.0%0.05%
+6.0%
Q3 2016$5,561,000
+52.9%
5,102,153
-0.4%
0.05%
+31.6%
Q2 2016$3,637,000
-43.5%
5,122,153
-6.8%
0.04%
-44.1%
Q1 2016$6,433,000
-68.3%
5,498,459
-33.6%
0.07%
-59.5%
Q4 2015$20,275,000
-7.9%
8,275,630
+12.8%
0.17%
-17.2%
Q3 2015$22,007,000
-27.4%
7,335,6920.0%0.20%
-23.7%
Q2 2015$30,296,000
-7.5%
7,335,692
-3.0%
0.27%
-2.2%
Q1 2015$32,758,000
+64.2%
7,565,462
+12.7%
0.27%
+33.3%
Q4 2014$19,945,000
-10.5%
6,715,4620.0%0.20%
-27.4%
Q3 2014$22,295,000
+296.4%
6,715,462
+202.1%
0.28%
+307.2%
Q2 2014$5,624,000
+336.6%
2,223,053
+290.1%
0.07%
+331.2%
Q1 2014$1,288,000569,8530.02%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders